Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tauro-Implant GmbH is a specialized healthcare company based in Winsen, Germany, focused on the distribution of advanced solutions for catheter management and infection prevention. As the exclusive German distributor for TauroPharm GmbH, the company provides a comprehensive portfolio of antimicrobial lock solutions, including the TauroLock™ and NutriLock™ product lines. These products are designed to prevent catheter-associated bloodstream infections (CRBSI) and maintain catheter patency in high-risk patient populations, such as those in dialysis, oncology, and parenteral nutrition. Additionally, Tauro-Implant offers TauroPace™, an antimicrobial solution for cardiac implantable electronic devices, and various procedural sets to optimize clinical workflows. The company supports healthcare providers with specialized training, literature, and reimbursement expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tauro-Implant.